Characterizing the Clinical Adoption of Medical AI Devices through U.S. Insurance Claims

• DOI: 10.1056/aioa2300030
• Publication Date: 2023-11-09T15:25:16Z
• Authors: Kevin Wu; Eric Wu; Brandon Theodorou; Weixin Liang; Christina Mack; Lucas Glass; Jimeng Sun; James Zou
• Keywords: Current Procedural Terminology

There are now over 500 medical artificial intelligence (AI) devices that approved by the U.S. Food and Drug Administration. However, little is known about where how often these actually used after regulatory approval. In this article, we systematically quantify adoption usage of AI in United States tracking Current Procedural Terminology (CPT) codes explicitly created for AI. CPT widely documenting billing payment procedures, providing a measure device utilization across different clinical settings. We examined comprehensive nationwide claims database 11 billion between January 1, 2018, June 2023 to analyze prevalence based on submitted claims. Our results indicate still nascent, with most driven handful leading devices. For example, only assessing coronary artery disease diagnosing diabetic retinopathy have accumulated more than 10,000 Furthermore, found zip had higher income level, were metropolitan, academic centers much likely usage. study sheds light current landscape States, underscoring need further investigate barriers incentives promote equitable access broader integration technologies health care.